Pharmacological and genetic inhibition of fatty acid‐binding protein 4 alleviated cisplatin‐induced acute kidney injury

Fatty acid‐binding protein 4 (FABP4) has been confirmed to be involved in the pathogenesis of ischaemia/reperfusion‐ and rhabdomyolysis‐induced acute kidney injury (AKI), and targeting inhibition of FABP4 might be a potential strategy for AKI. Cisplatin as a commonly used cancer chemotherapeutic dru...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Zhouke, Guo, Fan, Huang, Zhuo, Xia, Zijing, Liu, Jing, Tao, Sibei, Li, Lingzhi, Feng, Yuying, Du, Xiaoyan, Ma, Liang, Fu, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714212/
https://www.ncbi.nlm.nih.gov/pubmed/31286669
http://dx.doi.org/10.1111/jcmm.14512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714212/
https://www.ncbi.nlm.nih.gov/pubmed/31286669
http://dx.doi.org/10.1111/jcmm.14512

Ejemplares similares